VAERS reports by lot

GSK DTaP/Tdap lot T7E4A: VAERS reports

26 VAERS reports list lot T7E4A as a GSK DTaP/Tdap vaccine, received between 2018-05-25 and 2019-09-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3258%
Dermatological (non-injection-site)815%
Allergic / Anaphylactic611%
General / Systemic (non-local)47%
Respiratory24%
Neurological12%
Gastrointestinal12%
Musculoskeletal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Michigan3
Missouri2
New York2
Florida2
Texas2
Georgia2
Tennessee2
Illinois1
Minnesota1
Virginia1
Mississippi1

Reports by month received

2018-051
2018-061
2018-074
2018-084
2018-091
2018-106
2018-111
2018-123
2019-021
2019-052
2019-081
2019-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.